Pharmacology - 07:31
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Pharmacology - Sep 13
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
wire - news in brief
Category
Results 301 - 338 of 338.
Computational power in the fight against cancer
Vittorio Limongelli, Associate professor at the USI Faculty of Biomedical Sciences and at the USI Institute of Computational Science (ICS), has recently received a competitive research funding consis
Vittorio Limongelli, Associate professor at the USI Faculty of Biomedical Sciences and at the USI Institute of Computational Science (ICS), has recently received a competitive research funding consis
ETH Zurich publishes investigation report
A number of recent media reports on the request for dismissal of an ETH astronomy professor have included quotes from internal and confidential documents relating to the ongoing proceedings. Given the growing public interest, as well as the need to ensure transparency and fairness, ETH Zurich has decided to publish anonymised versions of the final report of the administrative investigation and the recommendation of the special committee.
A number of recent media reports on the request for dismissal of an ETH astronomy professor have included quotes from internal and confidential documents relating to the ongoing proceedings. Given the growing public interest, as well as the need to ensure transparency and fairness, ETH Zurich has decided to publish anonymised versions of the final report of the administrative investigation and the recommendation of the special committee.
Tech4Impact, founded in 2017, is EPFL's pioneering multi-stakeholder platform where students, researchers, large enterprises, NGOs and startups come together to enhance the university's social and environmental impact in the areas of education, research and innovation.
Showy Primates Have Smaller Testicles
Well-adorned or well-endowed ' but not both. Evolutionary biologists at the University of Zurich have for the first time demonstrated that male primates either have large testicles or showy ornaments. Developing both at the same time may simply take too much energy. Male primates are highly competitive, especially about one thing: fathering offspring.
Well-adorned or well-endowed ' but not both. Evolutionary biologists at the University of Zurich have for the first time demonstrated that male primates either have large testicles or showy ornaments. Developing both at the same time may simply take too much energy. Male primates are highly competitive, especially about one thing: fathering offspring.
Animal-assisted therapy can foster social competence in patients with brain injuries and increase their emotional involvement during therapy. These were the findings of a clinical trial conducted by psychologists from the University of Basel and published in the journal Scientific Reports. After a severe traumatic brain injury, patients often exhibit problems in their social behavior.
Interview with new group leader Guillaume Diss
Guillaume Diss joined the FMI as a new Quantitative Biology group leader on March 1. His research focuses on understanding the mechanisms whereby genetic variation translates into phenotypic variation - for example, in diseases.
Guillaume Diss joined the FMI as a new Quantitative Biology group leader on March 1. His research focuses on understanding the mechanisms whereby genetic variation translates into phenotypic variation - for example, in diseases.
Engineers working on the CleanSpace One project at EPFL's Space Center have come up with a way of capturing and destroying the space debris that has built up over 60 years of low-orbit activities. That team has now founded a startup, ClearSpace, to further develop and market the technology. Since 2012, engineers at EPFL's Space Center have been hard at work on a new junk-clearing satellite to capture debris orbiting the earth.
Fondation Botnar has awarded CHF 7 million to researchers from Lausanne for further deployment of electronic diagnostic and treatment tools based on algorithms, which will help clinicians to manage febrile children.
Three researchers at the University of Zurich have received an ERC Advanced Grant. A physicist, a mathematician and a theologian will each receive up to 2.5 million euros from the European Research Council to continue their research.
ETH researchers with new ERC Grants
In its latest awarding process for the ERC Advanced Grants, the European Research Council (ERC) has selected five projects being conducted by ETH Zurich researchers.
In its latest awarding process for the ERC Advanced Grants, the European Research Council (ERC) has selected five projects being conducted by ETH Zurich researchers.
Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc
Roche and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche's pending acquisition of Spark.
Roche and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche's pending acquisition of Spark.
Novartis first-in-class Cosentyx approved in China for psoriasis patients
China Health Authority NMPA approved Cosentyx (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy Cosentyx is the first b
China Health Authority NMPA approved Cosentyx (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy Cosentyx is the first b
AveXis expands world-leading gene therapy manufacturing capacity with purchase of advanced biologics therapy manufacturing campus in Longmont, Colorado
Facility to become the largest of four state-of-the-art sites involved in manufacturing of AveXis gene therapies for pipeline of rare genetic diseases including spinal muscular atrophy AveXis plans
Facility to become the largest of four state-of-the-art sites involved in manufacturing of AveXis gene therapies for pipeline of rare genetic diseases including spinal muscular atrophy AveXis plans
Professors Pierre Gönczy and Douglas Hanahan (School of Life Sciences), and Professor Tobias J. Kippenberg (School of Basic Sciences/School of Engineering) have been awarded ERC Advanced Grants.
Roche’s ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial
Data from Phase Ib study to be presented at American Association for Cancer Research (AACR) 2019 annual congress 73% overall response rate (ORR) irrespective of PD-L1 status or PI3KCA/AKT1/PTEN alter
Data from Phase Ib study to be presented at American Association for Cancer Research (AACR) 2019 annual congress 73% overall response rate (ORR) irrespective of PD-L1 status or PI3KCA/AKT1/PTEN alter
The agricultural technics of wild hay making in Switzerland and shifting cultivation in the eastern Himalayas have one thing in common: They are both performed on steep slopes.
Examining the highly organized lives of long-distance commuters
When both parents face lengthy commutes to work, how do families handle the additional stress' An EPFL scientist took an in-depth look at the strategies these parents use for managing their time wisely and dealing with unexpected challenges. "Most studies on long-distance commuters focus on high-ranking executives who live and work in different countries.
When both parents face lengthy commutes to work, how do families handle the additional stress' An EPFL scientist took an in-depth look at the strategies these parents use for managing their time wisely and dealing with unexpected challenges. "Most studies on long-distance commuters focus on high-ranking executives who live and work in different countries.
Novartis receives FDA approval for Mayzent (siponimod), the first oral drug to treat secondary progressive MS with active disease
Mayzent (siponimod) is the first and only treatment specifically approved for patients with active secondary progressive multiple sclerosis (SPMS) in over 15 years Up to 80% of patients with relaps
Mayzent (siponimod) is the first and only treatment specifically approved for patients with active secondary progressive multiple sclerosis (SPMS) in over 15 years Up to 80% of patients with relaps
Diesel vans are dirtier in winter than many know: Where there are still gaps in emissions legislation, soot particles and nitrogen oxides (NOx) continue to be produced.
Corinne Boss Takes Reins of ’Animals and Products of Animal Origin’ Competence Division at Agroscope
Corinne Boss is the new Head of Agroscope's 'Animals and Products of Animal Origin' Competence Division for Research Technology and Knowledge Transfer; in this capacity, she also becomes a Member of the Agroscope Executive Board. A biologist and official expert in animal health, Corinne Boss currently works at the Swiss Federal Office for Agriculture (FOAG) as a Research Scientist in the 'Products of Animal Origin and Livestock Breeding' Division.
Corinne Boss is the new Head of Agroscope's 'Animals and Products of Animal Origin' Competence Division for Research Technology and Knowledge Transfer; in this capacity, she also becomes a Member of the Agroscope Executive Board. A biologist and official expert in animal health, Corinne Boss currently works at the Swiss Federal Office for Agriculture (FOAG) as a Research Scientist in the 'Products of Animal Origin and Livestock Breeding' Division.
"No one may be left behind," writes Unesco in its World Water Report. Today, three out of ten people have no access to safe drinking water and even less to sanitation facilities, often because they are discriminated against for various reasons.
Official comment on recent media coverage
ETH Zurich provides an official comment on articles published recently in the online magazine Republik.
ETH Zurich provides an official comment on articles published recently in the online magazine Republik.
Pharmacology - 07:31
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Pharmacology - Sep 13
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis